Despite growing recognition of biomarker testing, access to evidence-based biomarker testing remains surprisingly fragmented. Healthcare delivery in the United States is highly decentralized. Physicians, laboratories, hospitals, specialists, and payors typically operate as independent...

The role of biomarker testing in clinical medicine has expanded significantly over the past decade. Once limited primarily to specialized research settings and select disease states, biomarker testing is increasingly being incorporated into routine clinical decision-making across a growing number...